Important Considerations in the Sale of Your Clients Business

Posted June 20, 2017 by OCP | Post a Comment

Objective Capital’s Channing Hamlet to present on

July 6, 2017 at Southern California Institute

San Diego, CA- June 26, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, Channing Hamlet, will be a panel speaker as part of Southern California Institute’s (SCI) Thursday Insights on July 6, 2017. Greg Banner of Asset Preservation Strategies, Inc.will join Mr. Hamlet in presenting Important Considerations in the Sale of Your Clients Business. In this session, Greg and Channing will cover a number of core concepts that advisors can use to advise clients at this critical juncture in their personal and business life.  Specifically, they will discuss methods to maximize sale price, assess the sale for fit with client's objectives, and methods to maximize after-tax cash.

(more…)

Press News, Sell-Side M&A

Objective Capital’s Dr. David Crean to Address Entrepreneurs on Due Diligence Issues

Posted June 15, 2017 by OCP | Post a Comment

San Diego Startup Week — June 19th - 23rd, 2017

San Diego, CA- June 19, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle-market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will be a panel speaker as part of San Diego Startup Week on June 19-23, 2017 in San Diego, CA. Dr. Crean will address issues to consider on due diligence from an investment banker’s perspective on June 21, 2017. He will be joined by fellow panelists Jeremy Glaser, Attorney and Partner at Mintz Levin, Brent Grenado, General Partner at Sway Ventures, Patrick Henry, CEO at Quest Fusion, and Walt Tendler, CFO at Mission Venture.

(more…)

Press News

Objective Capital’s Dr. David Crean to Judge Life Sciences Company Pitches at Start-Up Stadium 2017

Posted June 07, 2017 by OCP | Post a Comment

Start-up and Emerging Companies to Present at BIO2017

San Diego, CA- June 12, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle-market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as a Judge for company finalists during live presentations as part of BIO 2017 Start-Up Stadium on June 20-22, 2017 in San Diego, CA. As the world’s largest biotechnology event, the BIO International Convention provides several specialized opportunities geared towards start-up and emerging companies. The Start-Up Stadium was designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees.

(more…)

Life Sciences, Press News

The Math Behind the Aftermath Driving a Private-Public Merger Transaction: Mast Therapeutics and Savara

Posted June 02, 2017 by OCP | Post a Comment

Objective Capital’s Dr. David Crean to Moderate M&A

Panel Discussion for ACG San Diego on June 20, 2017

San Diego, CA- June 6, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as Moderator for ACG San Diego’s Hot Topics in Life Sciences M&A, June 20, 2017 at Lomas Santa Fe Country Club, Solana Beach, CA from 7-9 AM.

(more…)

Healthcare, Life Sciences, Press News, Technology

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com